Since exogenous IGFBP-3 can potentiate apoptosis following DNA damage [6–8, 29, 30, 53], the suppression of endogenous IGFBP-3 by an oncogenic mutant p53 might be expected to promote cancer cell survival. Here, TP53 is linked to cancer.